Metraipolis › archive › dc_fdb415259833

Effect of once-daily ICS/LAMA/LABA triple therapy versus ICS/LABA on respiratory symptoms (E-RS: Asthma): Analysis of the phase IIIA CAPTAIN trial — Europe PMC PMID:42438707

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42438707
DOI
10.1016/j.jacig.2026.100741
License (as archived)
solo-consultazione
Archived
2026-10-07T19:30:03.161Z
SHA-256 of the archived text
614bbd83bb399220966d14135992bb9eb73db99fa615abef971e341f09b024ac
Stable URL of this page
https://metraipolis.com/documento/dc_fdb415259833

How to cite

Effect of once-daily ICS/LAMA/LABA triple therapy versus ICS/LABA on respiratory symptoms (E-RS: Asthma): Analysis of the phase IIIA CAPTAIN trial — Europe PMC PMID:42438707 — Europe PMC (en), https://europepmc.org/article/MED/42438707 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdb415259833 (Metraipolis archive dc_fdb415259833, sha256 614bbd83bb399220966d14135992bb9eb73db99fa615abef971e341f09b024ac)
BibTeX
@misc{dcfdb415259833,
  title = {Effect of once-daily ICS/LAMA/LABA triple therapy versus ICS/LABA on respiratory symptoms (E-RS: Asthma): Analysis of the phase IIIA CAPTAIN trial — Europe PMC PMID:42438707},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42438707},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdb415259833; sha256 614bbd83bb399220966d14135992bb9eb73db99fa615abef971e341f09b024ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42438707. Agents can read the archived copy with the MCP tool read_document.